CIK 0001754068
- Non-accelerated filer
- Smaller reporting company
Kalaris Therapeutics, Inc.
Sign in to watch- Ticker
- KLRS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 831971007
- Phone
- +1 650-249-2727
- Business address
- 400 CONNELL DRIVE, SUITE 5500, BERKELEY HEIGHTS, NJ, 07922
- Former names
- Allovir, Inc., ViraCyte, Inc.
- 4 Open-market sale Director sold 200,002 shares at an average $31.34 ($6,268,101)
- 4 Open-market sale Director sold 97,689 shares at an average $33.50 ($3,272,798)
- 4 Open-market sale Director sold 63,836 shares at an average $38.41 ($2,451,760)
- 4 Open-market sale Chief Commercial Officer sold 5,932 shares at an average $38.78 ($230,034)
- 4 Open-market sale General Counsel sold 6,000 shares at an average $38.78 ($232,699)
- 4 Open-market sale Chief Scientific Officer sold 9,518 shares at an average $38.70 ($368,329)
- 4 Open-market sale Director sold 52,267 shares at an average $38.28 ($2,000,565)
- 4 Open-market sale Director sold 20,583 shares at an average $40.43 ($832,119)
- 4 Open-market sale Director sold 36,404 shares at an average $41.51 ($1,511,310)
- 4 Open-market sale Chief Commercial Officer sold 9,083 shares at an average $41.46 ($376,621)
- 4 Open-market sale Chief Scientific Officer sold 17,446 shares at an average $41.48 ($723,625)
- 4 Open-market sale Chief Accounting Officer sold 800 shares at $43.14 ($34,509)
- 4 Open-market sale Director sold 31,902 shares at an average $41.45 ($1,322,217)
- 4 Open-market sale Chief Scientific Officer sold 2,700 shares at an average $40.81 ($110,194)
- 4 Open-market sale Chief Accounting Officer sold 741 shares at an average $40.11 ($29,724)
- 4 Open-market sale Chief Commercial Officer sold 2,085 shares at an average $40.67 ($84,787)
- 4 Open-market sale Director sold 8,942 shares at an average $40.75 ($364,368)
- 4 Open-market sale Director sold 6,757 shares at an average $40.75 ($275,366)
- 4 Open-market sale Director sold 17,860 shares at an average $41.23 ($736,295)
- 4 Open-market sale Director sold 11,385 shares at an average $41.22 ($469,257)
Page 15 of 19 · 363 filings